Metabolic Regeneration Registry for Periodontal Health (20-Patient Cohort).
Retrospective Longitudinal Observation of a Proprietary Metabolic Protocol for Rapid Gingival Tissue Repair and Periodontal Pocket Stabilization.
1 other identifier
observational
20
1 country
1
Brief Summary
This observational study documents the clinical outcomes of a proprietary, safe-to-swallow metabolic protocol for chronic gum disease. Based on 21 years of research and a focused 20-patient cohort, the study records visible clinical improvements in gingival inflammation and tissue color within 7 to 14 days. The protocol focuses on restoring the metabolic environment to achieve non-surgical periodontal pocket stabilization and natural tissue re-attachment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 26, 2026
CompletedFirst Submitted
Initial submission to the registry
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
April 20, 2026
CompletedApril 28, 2026
April 1, 2026
2 months
April 13, 2026
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visible reduction in gingival inflammation and erythema (redness) observed within 7 to 14 days
7 to 14 days
Secondary Outcomes (1)
Measurement of periodontal pocket depth reduction and tissue stability at 6 weeks
6 weeks
Interventions
Topical application of a proprietary, 100% food-grade (GRAS) nutraceutical formulation specifically designed for rapid gingival tissue regeneration and inflammation reversal. Key Performance Indicators: Speed: Clinical onset of action visible within 3 days. Safety: Completely safe for ingestion (edible), eliminating common side effects of chemical antiseptics like staining or taste alteration. Efficacy: Significant reduction in redness and bleeding (BOP) within 7 to 14 days, as demonstrated in our cohort of 20+ subjects. Mechanism: Supports the natural healing of the gum 'peau' (epithelium) through host-response modulation rather than harsh disinfection.
Topical application of a proprietary, 100% food-grade (GRAS) nutraceutical formulation specifically designed for rapid gingival tissue regeneration and inflammation reversal.Key Performance Indicators: Speed: Clinical onset of action visible within 3 days. Safety: Completely safe for ingestion (edible), eliminating common side effects of chemical antiseptics like staining or taste alteration. Efficacy: Significant reduction in redness and bleeding (BOP) within 7 to 14 days, as demonstrated in our cohort of 20+ subjects. Mechanism: Supports the natural healing of the gum 'peau' (epithelium) through host-response modulation rather than harsh disinfection."
Eligibility Criteria
Patients aged 18 to 75 years diagnosed with chronic periodontitis, characterized by gingival inflammation, bleeding on probing, and periodontal pocket depths of 4mm or greater. The population includes individuals seeking non-surgical alternatives for gum tissue recovery.
You may qualify if:
- Patients (18-75) with documented chronic periodontitis and pocket depths \>4mm.
You may not qualify if:
- Active oral malignancy or pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amar h Zireglead
- Self fundedcollaborator
Study Sites (1)
Zireg
Bordj Bou Arreridj, Wilaya de Bordj Bou Arréridj, 34000, Algeria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- sponsor investigator
Study Record Dates
First Submitted
April 13, 2026
First Posted
April 20, 2026
Study Start
January 3, 2026
Primary Completion
February 20, 2026
Study Completion
February 26, 2026
Last Updated
April 28, 2026
Record last verified: 2026-04